수의 검사 기관 시장 예측(-2034년) : 동물 유형, 검사 유형별, 질환 영역, 기술, 검체 유형별, 최종사용자, 서비스 유형별, 소요 시간, 용도 및 지역별 세계 분석

According to Stratistics MRC, the Global Veterinary Reference Laboratory Market is accounted for $5.8 billion in 2026 and is expected to reach $12.1 billion by 2034 growing at a CAGR of 9.5% during the forecast period. Veterinary reference laboratories are specialized diagnostic facilities that provide advanced testing services for animal health, supporting veterinarians in disease diagnosis, treatment planning, and health monitoring. These laboratories utilize a wide range of technologies including clinical biochemistry analyzers, immunoassay technologies, molecular diagnostic technologies, microbiology technologies, digital pathology, flow cytometry, mass spectrometry, and other diagnostic platforms. Testing is performed on various sample types including blood, serum and plasma, urine, fecal samples, tissue samples, saliva, milk, swab samples, and other biological specimens. Growing pet ownership, increasing demand for advanced diagnostic services, rising prevalence of zoonotic and chronic diseases, and technological advancements in veterinary diagnostics are key drivers of market expansion across all regions.

Market Dynamics:

Driver:

Increasing pet ownership and demand for advanced diagnostic services

The rising global pet population and growing demand for sophisticated veterinary diagnostic services are primary drivers for the veterinary reference laboratory market. Pet owners increasingly expect advanced diagnostic capabilities comparable to human healthcare, including comprehensive laboratory testing for accurate disease diagnosis and monitoring. The humanization of pets has led to greater investment in preventive and specialty care, driving demand for reference laboratory services. As veterinary practices expand services and referral networks grow, reference laboratory utilization increases. Growing awareness of the benefits of early disease detection through comprehensive testing further supports market growth. These trends across developed and emerging markets sustain strong demand for veterinary reference laboratory services.

Restraint:

High testing costs and limited insurance coverage

The significant costs associated with advanced veterinary diagnostic testing and limited insurance coverage represent a major restraint for the market. Comprehensive reference laboratory testing can be expensive, potentially limiting access for some pet owners. Veterinary insurance coverage varies across regions and may not cover all diagnostic tests. Pet owners may face financial constraints that limit testing utilization. Practices may be reluctant to recommend extensive testing without clear reimbursement pathways. These cost barriers may limit testing volumes, particularly in price-sensitive markets and for less critical conditions.

Opportunity:

Technological advancements in veterinary diagnostics

Continuous innovation in diagnostic technologies presents significant opportunities for veterinary reference laboratory market expansion. Molecular diagnostic technologies including PCR and next-generation sequencing are enabling more accurate and rapid disease detection. Digital pathology and AI-assisted diagnostics are improving interpretation accuracy and efficiency. Point-of-care testing advancements are complementing reference laboratory services. Novel biomarker discovery is expanding diagnostic capabilities. Automation and laboratory information systems are improving operational efficiency. As technology advances and becomes more accessible, new testing applications and improved service delivery capture growing market share.

Threat:

Consolidation of veterinary practices and in-house testing expansion

The trend toward consolidation of veterinary practices into large corporate groups and the expansion of in-house testing capabilities pose significant threats to reference laboratory market growth. Corporate veterinary groups may centralize testing or develop their own laboratory networks, reducing external reference laboratory utilization. Advances in point-of-care and in-house testing equipment enable more comprehensive testing within practices. Some previously reference-only tests are becoming available for in-house use. This trend may limit growth in reference laboratory testing volumes for certain test categories.

Covid-19 Impact:

The COVID-19 pandemic had a significant impact on the veterinary reference laboratory market. Initial disruptions included reduced veterinary visits during lockdowns and supply chain interruptions. However, pet adoption surged during the pandemic, expanding the patient population. The pandemic highlighted the importance of diagnostic testing for zoonotic disease surveillance. Telemedicine and remote consultation expanded, increasing demand for diagnostic testing services. Reference laboratories adapted operations for safety. Post-pandemic, elevated pet ownership and continued focus on animal health have sustained demand for diagnostic services, with reference laboratories maintaining essential roles in veterinary care.

The Clinical Biochemistry Analyzers segment is expected to be the largest during the forecast period

The Clinical Biochemistry Analyzers segment is expected to account for the largest market share during the forecast period, driven by their essential role in routine diagnostic testing for evaluating organ function, metabolic status, and overall health in animals. Clinical biochemistry testing is among the most frequently ordered laboratory services in veterinary medicine, providing critical information for diagnosis and monitoring. The segment benefits from established technology, high testing volumes, and broad application across all animal species. Continuous automation and efficiency improvements support laboratory operations. With high testing volumes and essential diagnostic role, clinical biochemistry analyzers maintain the largest market share.

The Swab Samples segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Swab Samples segment is predicted to witness the highest growth rate, fueled by increasing infectious disease testing, growing demand for respiratory pathogen detection, and the expansion of molecular diagnostic applications. Swab samples are essential for infectious disease diagnosis in both companion animals and livestock. The segment benefits from growing surveillance for zoonotic and emerging infectious diseases. Increasing demand for rapid molecular testing for respiratory pathogens supports growth. As infectious disease testing expands and molecular diagnostics adoption increases, swab samples deliver the fastest segment growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership rates, strong spending on veterinary care, and advanced veterinary diagnostic infrastructure. The United States leads regional market growth with substantial investment in veterinary reference laboratories and diagnostic services. High awareness of advanced diagnostic options among pet owners supports demand. Strong presence of veterinary diagnostic companies and technology innovation drives adoption. Established referral networks and specialty practices create consistent demand. With high pet spending and advanced diagnostic infrastructure, North America maintains its dominant market position.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by rising pet ownership, expanding veterinary healthcare infrastructure, and increasing awareness of advanced diagnostic services across countries including China, India, Australia, and Southeast Asia. The region's rapidly growing pet population and expanding middle class create substantial demand for veterinary diagnostic services. Veterinary practice modernization and technology adoption are accelerating. Increasing investment in veterinary laboratory infrastructure and specialist training is expanding service availability. Growing awareness of diagnostic testing benefits and increasing insurance coverage support market expansion. As veterinary healthcare develops, Asia Pacific delivers the fastest veterinary reference laboratory market growth globally.

Key players in the market

Some of the key players in Veterinary Reference Laboratory Market include IDEXX Laboratories, Inc., Antech Diagnostics, Zoetis Inc., Mars Incorporated, Heska Corporation, Neogen Corporation, Virbac S.A., Randox Laboratories Ltd., MiDOG Animal Diagnostics, National Veterinary Services Laboratories, Vetnostics, Gribbles Veterinary, NationWide Laboratories, Finn Pathologists, Biobest Laboratories, Animal Health Diagnostic Center, University of California, Davis Veterinary Medical Teaching Hospital, and Texas A&M Veterinary Medical Diagnostic Laboratory.

Key Developments:

In May 2026, IDEXX expanded its reference laboratory and point-of-care Fecal Dx(R) antigen testing platform with the global commercial launch of Taeniid Tapeworm Detection, enabling accurate screening for tapeworm infections in companion animals.

In March 2026, Zoetis entered into a definitive agreement to acquire the global animal genomics business from Neogen(R) Corporation, incorporating specialized genomic sequencing and diagnostic reference workflows into its precision animal health portfolio.

In March 2026, Neogen announced the strategic sale and divestiture of its global animal genomics business unit to Zoetis Inc., reallocating capital to focus on its core food safety and sanitation testing product lines.

In January 2026, Antech launched RapidRead(TM) Dental for Feline, an AI-driven dental radiology interpretation tool built for cats, and integrated Symmetric Dimethylarginine (SDMA) kidney function biomarker testing onto its in-house Element i+ diagnostic platform at VMX 2026.

Animal Types Covered:

• Companion Animals
• Livestock Animals

Test Types Covered:

• Clinical Chemistry
• Hematology
• Microbiology
• Parasitology
• Histopathology and Cytopathology
• Immunodiagnostics
• Molecular Diagnostics
• Toxicology Testing
• Endocrinology Testing
• Allergy Testing
• Other Test Types

Disease Areas Covered:

• Infectious Diseases
• Parasitic Diseases
• Metabolic Disorders
• Endocrine Disorders
• Gastrointestinal Diseases
• Dermatological Diseases
• Oncology
• Cardiovascular Disorders
• Reproductive Disorders
• Other Disease Areas

Technologies Covered:

• Clinical Biochemistry Analyzers
• Immunoassay Technologies
• Molecular Diagnostic Technologies
• Microbiology Technologies
• Digital Pathology
• Flow Cytometry
• Mass Spectrometry
• Other Technologies

Sample Types Covered:

• Blood
• Serum and Plasma
• Urine
• Fecal Samples
• Tissue Samples
• Saliva
• Milk
• Swab Samples
• Other Sample Types

End Users Covered:

• Veterinary Hospitals
• Veterinary Clinics
• Veterinary Diagnostic Laboratories
• Animal Research Institutes
• Academic and Veterinary Universities
• Livestock Farms and Producers
• Government and Public Health Organizations
• Other End Users

Service Types Covered:

• Routine Diagnostic Testing
• Specialized Diagnostic Testing
• Preventive Health Screening
• Disease Surveillance Testing
• Genetic Testing
• Toxicology Services
• Consultation and Interpretation Services
• Other Service Types

Turnaround Times Covered:

• Same Day
• Within 24 Hours
• Two to Three Days
• More Than Three Days

Applications Covered:

• Disease Diagnosis
• Preventive Healthcare
• Herd Health Management
• Companion Animal Wellness Monitoring
• Food Safety and Zoonotic Disease Surveillance
• Breeding and Reproductive Health
• Research and Clinical Trials
• Other Applications

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Veterinary Reference Laboratory Market, By Animal Type

• 5.1 Companion Animals
  • 5.1.1 Dogs
  • 5.1.2 Cats
  • 5.1.3 Horses
  • 5.1.4 Other Companion Animals
• 5.2 Livestock Animals
  • 5.2.1 Cattle
  • 5.2.2 Poultry
  • 5.2.3 Swine
  • 5.2.4 Sheep and Goats
  • 5.2.5 Aquaculture
  • 5.2.6 Other Livestock Animals

6 Global Veterinary Reference Laboratory Market, By Test Type

• 6.1 Clinical Chemistry
• 6.2 Hematology
• 6.3 Microbiology
• 6.4 Parasitology
• 6.5 Histopathology and Cytopathology
• 6.6 Immunodiagnostics
• 6.7 Molecular Diagnostics
  • 6.7.1 PCR Testing
  • 6.7.2 Next-Generation Sequencing (NGS)
  • 6.7.3 DNA and RNA Testing
• 6.8 Toxicology Testing
• 6.9 Endocrinology Testing
• 6.10 Allergy Testing
• 6.11 Other Test Types

7 Global Veterinary Reference Laboratory Market, By Disease Area

• 7.1 Infectious Diseases
• 7.2 Parasitic Diseases
• 7.3 Metabolic Disorders
• 7.4 Endocrine Disorders
• 7.5 Gastrointestinal Diseases
• 7.6 Dermatological Diseases
• 7.7 Oncology
• 7.8 Cardiovascular Disorders
• 7.9 Reproductive Disorders
• 7.10 Other Disease Areas

8 Global Veterinary Reference Laboratory Market, By Technology

• 8.1 Clinical Biochemistry Analyzers
• 8.2 Immunoassay Technologies
• 8.3 Molecular Diagnostic Technologies
• 8.4 Microbiology Technologies
• 8.5 Digital Pathology
• 8.6 Flow Cytometry
• 8.7 Mass Spectrometry
• 8.8 Other Technologies

9 Global Veterinary Reference Laboratory Market, By Sample Type

• 9.1 Blood
• 9.2 Serum and Plasma
• 9.3 Urine
• 9.4 Fecal Samples
• 9.5 Tissue Samples
• 9.6 Saliva
• 9.7 Milk
• 9.8 Swab Samples
• 9.9 Other Sample Types

10 Global Veterinary Reference Laboratory Market, By End User

• 10.1 Veterinary Hospitals
• 10.2 Veterinary Clinics
• 10.3 Veterinary Diagnostic Laboratories
• 10.4 Animal Research Institutes
• 10.5 Academic and Veterinary Universities
• 10.6 Livestock Farms and Producers
• 10.7 Government and Public Health Organizations
• 10.8 Other End Users

11 Global Veterinary Reference Laboratory Market, By Service Type

• 11.1 Routine Diagnostic Testing
• 11.2 Specialized Diagnostic Testing
• 11.3 Preventive Health Screening
• 11.4 Disease Surveillance Testing
• 11.5 Genetic Testing
• 11.6 Toxicology Services
• 11.7 Consultation and Interpretation Services
• 11.8 Other Service Types

12 Global Veterinary Reference Laboratory Market, By Turnaround Time

• 12.1 Same Day
• 12.2 Within 24 Hours
• 12.3 Two to Three Days
• 12.4 More Than Three Days

13 Global Veterinary Reference Laboratory Market, By Application

• 13.1 Disease Diagnosis
• 13.2 Preventive Healthcare
• 13.3 Herd Health Management
• 13.4 Companion Animal Wellness Monitoring
• 13.5 Food Safety and Zoonotic Disease Surveillance
• 13.6 Breeding and Reproductive Health
• 13.7 Research and Clinical Trials
• 13.8 Other Applications

14 Global Veterinary Reference Laboratory Market, By Geography

• 14.1 North America
  • 14.1.1 United States
  • 14.1.2 Canada
  • 14.1.3 Mexico
• 14.2 Europe
  • 14.2.1 United Kingdom
  • 14.2.2 Germany
  • 14.2.3 France
  • 14.2.4 Italy
  • 14.2.5 Spain
  • 14.2.6 Netherlands
  • 14.2.7 Belgium
  • 14.2.8 Sweden
  • 14.2.9 Switzerland
  • 14.2.10 Poland
  • 14.2.11 Rest of Europe
• 14.3 Asia Pacific
  • 14.3.1 China
  • 14.3.2 Japan
  • 14.3.3 India
  • 14.3.4 South Korea
  • 14.3.5 Australia
  • 14.3.6 Indonesia
  • 14.3.7 Thailand
  • 14.3.8 Malaysia
  • 14.3.9 Singapore
  • 14.3.10 Vietnam
  • 14.3.11 Rest of Asia Pacific
• 14.4 South America
  • 14.4.1 Brazil
  • 14.4.2 Argentina
  • 14.4.3 Colombia
  • 14.4.4 Chile
  • 14.4.5 Peru
  • 14.4.6 Rest of South America
• 14.5 Rest of the World (RoW)
  • 14.5.1 Middle East
    • 14.5.1.1 Saudi Arabia
    • 14.5.1.2 United Arab Emirates
    • 14.5.1.3 Qatar
    • 14.5.1.4 Israel
    • 14.5.1.5 Rest of Middle East
  • 14.5.2 Africa
    • 14.5.2.1 South Africa
    • 14.5.2.2 Egypt
    • 14.5.2.3 Morocco
    • 14.5.2.4 Rest of Africa

15 Strategic Market Intelligence

• 15.1 Industry Value Network and Supply Chain Assessment
• 15.2 White-Space and Opportunity Mapping
• 15.3 Product Evolution and Market Life Cycle Analysis
• 15.4 Channel, Distributor, and Go-to-Market Assessment

16 Industry Developments and Strategic Initiatives

• 16.1 Mergers and Acquisitions
• 16.2 Partnerships, Alliances, and Joint Ventures
• 16.3 New Service Launches and Accreditations
• 16.4 Laboratory Expansion and Investments
• 16.5 Digital Transformation and AI Integration
• 16.6 Other Strategic Initiatives

17 Company Profiles

• 17.1 IDEXX Laboratories, Inc.
• 17.2 Antech Diagnostics
• 17.3 Zoetis Inc.
• 17.4 Mars Incorporated
• 17.5 Heska Corporation
• 17.6 Neogen Corporation
• 17.7 Virbac S.A.
• 17.8 Randox Laboratories Ltd.
• 17.9 MiDOG Animal Diagnostics
• 17.10 National Veterinary Services Laboratories
• 17.11 Vetnostics
• 17.12 Gribbles Veterinary
• 17.13 NationWide Laboratories
• 17.14 Finn Pathologists
• 17.15 Biobest Laboratories
• 17.16 Animal Health Diagnostic Center
• 17.17 University of California, Davis Veterinary Medical Teaching Hospital
• 17.18 Texas A&M Veterinary Medical Diagnostic Laboratory